Promestriene
- Level
- Commodity
- Parent
- 51351600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51351616This classification denotes a therapeutic estrogen with the molecular formula C22H32O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GXM4PER6WZ, chemically known as 17beta-methoxy-3-propoxyestra-1,3,5(10)-triene but generally known as promestriene, which bears US NIH Compound Identifier 71717. European Medicines Agency schedules Promestriene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10087MIG. The term PROMESTRIENE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). World Health Organization schedules promestriene in its Anatomical Therapeutic Chemical (ATC) Classification. PROMESTRIENE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule promestriene under HS 29372300 and SITC 54153. As of Q4 2014, PROMESTRIENE remains the US FDA Preferred Term for this commodity. Promestriene bears US NLM identifiers UMLS ID C0072151 and NCI Concept Code C76998. SMILES: O(C1C2(C(C3C(CC2)c2c(CC3)cc(OCCC)cc2)CC1)C)C.
Same parent
Under 51351600 · 35Activities that produce or sell this
KBLI · 8Inherited from family 51350000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.